Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -2.66% | -12.18% | -72.73% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 39.83 | 13.94 | 4.389 | 4.285 | 1.855 | - | - |
Enterprise Value (EV) 1 | 39.83 | 13.94 | 4.389 | 4.285 | 1.855 | 1.855 | 1.855 |
P/E ratio | -3.58 x | -1.8 x | -0.5 x | -0.39 x | -0.21 x | -0.37 x | -0.51 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - | - |
EV / FCF | -15,515,480 x | - | - | - | - | - | - |
FCF Yield | -0% | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 891 | 1,048 | 1,063 | 1,558 | 2,474 | - | - |
Reference price 2 | 44.70 | 13.30 | 4.127 | 2.750 | 0.7500 | 0.7500 | 0.7500 |
Announcement Date | 21-03-18 | 22-03-16 | 23-03-15 | 24-02-29 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | - | -1.671 | -7.208 | -8.869 | -9.584 | -22.1 | -26.01 | -26.49 |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -3.833 | -7.24 | -8.783 | -9.336 | -22.04 | -26.01 | -26.49 |
Net income 1 | -1.279 | -4.053 | -7.246 | -8.792 | -9.344 | -22.04 | -26.01 | -26.49 |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -13.90 | -12.50 | -7.400 | -8.200 | -7.140 | -3.500 | -2.020 | -1.480 |
Free Cash Flow | - | -2.567 | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 20-06-30 | 21-03-18 | 22-03-16 | 23-03-15 | 24-02-29 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -1.741 | -1.672 | -1.845 | -2.096 | -3.256 | -2.416 | -2.252 | -1.352 | -3.564 | -5.565 | -5.676 | -5.79 | -5.067 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -1.727 | -1.694 | -1.823 | -2.109 | -3.157 | -2.308 | -2.181 | 0.036 | -4.883 | -5.506 | -5.676 | -5.79 | -5.067 |
Net income 1 | -1.733 | -1.694 | -1.823 | -2.109 | -3.166 | -2.308 | -2.181 | 0.036 | -4.891 | -5.506 | -5.676 | -5.79 | -5.067 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -1.700 | -1.600 | -1.700 | -2.000 | -2.900 | -2.200 | -1.920 | 0.4800 | -3.500 | -2.720 | -1.040 | -0.8800 | -0.4400 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22-03-16 | 22-05-16 | 22-08-15 | 22-11-14 | 23-03-15 | 23-05-15 | 23-08-10 | 23-11-15 | 24-02-29 | 24-05-15 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | -2.57 | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 20-06-30 | 21-03-18 | 22-03-16 | 23-03-15 | 24-02-29 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.73% | 1.86M | |
+37.78% | 723B | |
+31.50% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.38% | 244B | |
-4.58% | 208B | |
+10.19% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- PRFX Stock
- Financials PainReform Ltd.